Edesa Biotech
EDSA
8 hedge funds and large institutions have $280K invested in Edesa Biotech in 2019 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 4 closing their positions.
189% more capital invested
Capital invested by funds: $97K → $280K (+$183K)
0.04% more ownership
Funds ownership: 0.04% → 0.08% (+0.04%)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
27% less funds holding
Funds holding: 11 → 8 (-3)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$109K |
| 2 |
Renaissance Technologies
New York
|
+$73K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$3.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$17K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$12K |
| 3 |
AG
Advisor Group
Phoenix,
Arizona
|
-$528 |
| 4 |
AWM
AllSquare Wealth Management
Albany,
New York
|
-$44 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $151K | +$73K | +1,659 | +118% |
|
|
2
Morgan Stanley
New York
| $122K | +$109K | +2,476 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| $7K | +$3.3K | +75 | +119% |
|
|
VF
4
Virtu Financial
New York
| – | -$17K | -380 | Closed |
|
|
TSS
5
Two Sigma Securities
New York
| – | -$12K | -265 | Closed |
|
|
AG
6
Advisor Group
Phoenix,
Arizona
| – | -$528 | -12 | -57% |
|
|
AWM
7
AllSquare Wealth Management
Albany,
New York
| – | -$44 | -1 | -50% |
|
EDSA Hedge Fund Activity: Q2 2019 in Review
8 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Edesa Biotech (EDSA) for Q2 2019, worth a combined $280K — up 189% from $97K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of EDSA and 1 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 2 added.
The largest buyer was Morgan Stanley, opening a new position worth an estimated $109K. The largest seller was Virtu Financial, exiting entirely with an estimated $17K sold.
- 8 institutional investors held Edesa Biotech (EDSA) as of Q2 2019, down from 11 in Q1 2019.
- Funds reported $280K of Edesa Biotech stock for Q2 2019, up 189% quarter-over-quarter.
- 1 fund opened new Edesa Biotech positions in Q2 2019 and 4 closed out, a net change of -3 holders.
- The largest Edesa Biotech buyer in Q2 2019 was Morgan Stanley, an estimated $109K added.
- The largest Edesa Biotech seller in Q2 2019 was Virtu Financial, an estimated $17K sold.
Based on aggregated 13F filings for Q2 2019.